Wilbanks Smith & Thomas Asset Management’s Novo Nordisk NVO Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.12M	Sell
2023 Q4	$909K	Buy
2023 Q3	$792K	Buy
2023 Q2	$241K	Sell
2023 Q1	$289K	Buy
2022 Q4	$242K	Buy
2018 Q4	–	Sell
2018 Q3	$65K	Buy